Tempest Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire· 2025-05-13 20:28
Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment of familial adenomatous polyposis (FAP)Received FDA “Study May Proceed” letter for Phase 2 trial of TPST-1495 for the treatment of FAPGranted both Orphan Drug & Fast Track designations by FDA for Amezalpat (TPST-1120) for the treatment of patients with hepatocellular carcinoma (HCC) BRISBANE, Calif., May 1 ...
Skyward Specialty Recruits Corey LaFlamme to Lead Captives & Specialty Programs Divisions; Hill Transitions To Divisions' Chairman
GlobeNewswire News Room· 2025-05-13 20:25
HOUSTON, May 13, 2025 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc.™ (Nasdaq: SKWD) ("Skyward Specialty" or "the Company") a leader in the specialty property and casualty (P&C) market, announced today the Company has recruited Corey LaFlamme to assume the role of President, Captives & Specialty Programs, marking a key strategic move to support its continued growth in one of the fastest-expanding segments of the specialty market. Additionally, the Company announced that Kirby Hill, who has play ...
Satellogic Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire· 2025-05-13 20:23
Revenue of $3.4 million in 1Q 2025 Domestication to U.S. Completed Awarded $30 Million Contract for AI-First Constellation and Closed $20 Million Registered Direct Offering NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Satellogic Inc. (NASDAQ: SATL), a leader in sub-meter resolution Earth Observation (“EO”) data collection, today provided a business update and reported its financial results for the three months ended March 31, 2025. “The year is off to a great start with our recent announcements in April relat ...
Alaris Equity Partners Announces $75 Million Bought Deal Offering of 6.50% Convertible Unsecured Senior Debentures
GlobeNewswire· 2025-05-13 20:22
NOT FOR DISTRIBUTION IN THE UNITED STATES.FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW CALGARY, Alberta, May 13, 2025 (GLOBE NEWSWIRE) -- Alaris Equity Partners Income Trust (“Alaris” or the “Trust”) (TSX: AD.UN) is pleased to announce that it has entered into an agreement with a syndicate of underwriters (the “Underwriters”) led by National Bank Financial, CIBC Capital Markets and Desjardins Capital Markets, and including Acumen Capital Partners, Raymon ...
Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer
GlobeNewswire· 2025-05-13 20:15
Core Insights - Avadel Pharmaceuticals has appointed Susan Rodriguez as Chief Operating Officer to lead the company's commercial strategy and operations, particularly in relation to the launch of LUMRYZ [1][2][17] - Rodriguez brings over 30 years of experience in the life sciences industry, having held leadership roles in various biopharmaceutical companies, which positions her well to support Avadel's growth and market expansion [2][17] Company Developments - LUMRYZ, an extended-release sodium oxybate medication, was approved by the FDA on May 1, 2023, as the first and only once-at-bedtime treatment for cataplexy or excessive daytime sleepiness in adults with narcolepsy [3][5][17] - The FDA also approved LUMRYZ for pediatric patients aged 7 years and older on October 16, 2024, further expanding its market potential [3][5] Clinical and Regulatory Highlights - The approval of LUMRYZ was supported by the REST-ON™ Phase 3 trial, which demonstrated significant improvements in excessive daytime sleepiness, overall patient functioning, and cataplexy attacks compared to placebo [4][5] - LUMRYZ has been granted 7 years of Orphan Drug Exclusivity due to its clinical superiority over existing treatments, providing a once-nightly dosing regimen that enhances patient care [5][6] Market Position and Strategy - The company aims to scale operations to meet increasing patient demand for LUMRYZ, particularly in the narcolepsy community, and is exploring potential label expansion to include idiopathic hypersomnia [2][17] - Rodriguez's expertise in launching innovative therapies in rare diseases is expected to be instrumental in accelerating the growth of LUMRYZ and maximizing its market impact [2][17]
FreightCar America, Inc. to Attend Wolfe Transportation & Industrials Conference
GlobeNewswire· 2025-05-13 20:15
Core Viewpoint - FreightCar America, Inc. will participate in the Wolfe 18th Annual Global Transportation & Industrials Conference on May 20, 2025, indicating its engagement with investors and the industry [1]. Company Overview - FreightCar America is a diversified manufacturer and supplier of railroad freight cars, railcar parts, and components, headquartered in Chicago, Illinois [3]. - The company specializes in railcar repairs, complete railcar rebody services, and railcar conversions, which repurpose idled rail assets back into revenue service [3]. - Established in 1901, FreightCar America has built a reputation for quality railcars that are essential for economic growth and the North American supply chain [3].
Waldencast Reports Q1 2025 Financial Results
GlobeNewswire· 2025-05-13 20:15
Financial Performance - Q1 2025 net revenue was $65.4 million, representing a 4.1% decline from Q1 2024 [4][10] - Adjusted gross margin improved to 76.4%, an increase of 10 basis points year-over-year [5][10] - Adjusted EBITDA for Q1 2025 was $4.4 million, or 6.7% of net revenue, reflecting a significant decline of 61.5% compared to Q1 2024 [6][10] Brand Performance - Milk Makeup's net revenue decreased by 15.1% to $29.3 million, impacted by the previous year's successful product launch and inventory reductions [12][13] - Obagi Medical achieved net revenue of $36.2 million, up 7.1% from $33.8 million in Q1 2024, driven by strong direct-to-consumer sales [13][10] Strategic Initiatives - The company is increasing marketing investments by high teens percentage to build brand equity and support long-term growth objectives [3][5] - Milk Makeup's entry into Ulta Beauty and the launch of Hydro Grip Gel Tint are expected to drive future sales growth [3][12] Liquidity and Debt - Waldencast secured a new $205 million five-year credit facility, enhancing financial flexibility and extending debt maturity to March 2030 [7][8] - As of March 31, 2025, the company held $10.8 million in cash and cash equivalents and had a net debt of $172.1 million [8][10] Outlook - The company aims for mid-teens net revenue growth and an adjusted EBITDA margin in the mid-to-high teens for fiscal 2025 [14][15]
Sow Good Unveils New Freeze Dried Caramel and Raw Caramel at Sweets & Snacks Expo
GlobeNewswire· 2025-05-13 20:15
Core Insights - Sow Good Inc. is launching two new products: Freeze Dried Caramel and Raw Caramel at the 2025 Sweets & Snacks Expo [3] - The new products will be available for purchase starting June 2025 through the company's website and retail partners [4] - Sow Good Inc. focuses on innovative freeze drying techniques to transform traditional confections, aiming to deliver unique textures and flavors [5] Product Details - Freeze Dried Caramel: A product designed to offer a unique texture and flavor experience [3] - Raw Caramel: Another innovative offering that complements the freeze dried variant [3] - Seasonal SKUs will also be launched at the end of the second quarter [3] Company Background - Sow Good Inc. is based in Dallas, TX, and is dedicated to reimagining classic treats through innovative techniques [5] - The company emphasizes the production of its confections in the USA [4]
THOR Industries, Inc. Welcomes Seth Woolf to Executive Team
GlobeNewswire· 2025-05-13 20:15
Core Insights - THOR Industries, Inc. has appointed Seth Woolf as Head of Corporate Development & Investor Relations, aiming to enhance long-term corporate initiatives and capital markets communications [1][2] - Woolf brings over 15 years of investment industry experience, particularly in the recreational vehicle sector, which will aid THOR in navigating market dynamics and supporting growth [2] Company Overview - THOR Industries is the largest manufacturer of recreational vehicles globally, owning several operating subsidiaries [3]
Uniti Group Inc. to Participate at the Barclays 2025 Leveraged Finance Conference
GlobeNewswire· 2025-05-13 20:15
Core Viewpoint - Uniti Group Inc. is actively participating in the Barclays 2025 Leveraged Finance Conference, indicating its engagement with investors and the financial community [1]. Company Overview - Uniti is an internally managed real estate investment trust focused on acquiring and constructing mission-critical communications infrastructure [3]. - The company is a leading provider of fiber and wireless solutions for the communications industry [3]. - As of March 31, 2025, Uniti owns approximately 147,000 fiber route miles and 8.8 million fiber strand miles across the United States [3]. Investor Relations - Key executives, including the Chief Financial Officer and the Senior Vice President of Investor Relations, will represent Uniti at the conference [1]. - Investor materials related to the conference will be available on Uniti's Investor Relations website [2].